Biocryst Pharmaceuticals (BCRX.MX) Q2 2024 Earnings

May 6Confirmed
Q4 2023
Q2 2024
-5.3
-4.49
-3.68
-2.87

Details

Expected EPS
-3.5313198668999997
Actual EPS
-2.867577
Surprise EPS
0.66
Surprise Percent
+18.8%

Description

⁨Biocryst Pharmaceuticals⁩ (⁦BCRX.MX⁩) has reported earnings of ⁦-2.867577⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts